BioPharma Credit Investments V GP LLC

BioPharma Credit Investments V LP

This is the fifth vintage in an established BioPharma Credit series, filed as an amendment rather than an initial filing—a signal that the fund was likely seeded or closed to existing investors before this mid-2026 amendment, possibly to expand capacity or adjust terms for incoming LPs without re-launching the entire raise.

BioPharma Credit Investments V (Cayman) LP

This is the fifth vintage in a series, filed as an amendment in May 2026, indicating the manager is recycling capital from prior funds rather than launching a wholly new strategy—a continuation pattern typical of established credit platforms seeking to maintain LP relationships across market cycles.